Akebia Therapeutics, Inc. (AKBA) vs Invivyd, Inc. (IVVD)
A side-by-side comparison of Akebia Therapeutics, Inc. and Invivyd, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AKBA
Akebia Therapeutics, Inc.
$0.88HealthcareDelayed quote: Oct 6, 2026, 10:10 AM EDT
IVVD
Invivyd, Inc.
$0.85HealthcareDelayed quote: Oct 6, 2026, 10:05 AM EDT
Total return — AKBA vs IVVD
growth of $100 · dividends reinvested · last 5yAKBA -64.6% (-18.7%/yr)IVVD -96.0% (-47.4%/yr)AKBA compounded faster over this window
Log scale — wide-divergence pair
AKBA IVVD
AKBA vs IVVD: by the numbers
- •IVVD is the larger company ($251M vs $237M market cap).
- •Both run net losses; AKBA's is the smaller (-13.54% vs -183.90% net margin).
Metrics side by side
Valuation
| Metric | AKBA | IVVD |
|---|---|---|
| P/S ratio | 1.08 | 4.31 |
| P/B ratio | 9.47 | 1.39 |
| FCF yield | 16.96% | N/A |
Profitability
| Metric | AKBA | IVVD |
|---|---|---|
| Gross margin | 79.48% | 91.35% |
| Operating margin | 9.95% | -103.99% |
| Net margin | -13.54% | -183.90% |
| ROE | -118.58% | -59.27% |
| ROIC | -7.08% | -59.90% |
Growth (annualized)
| Metric | AKBA | IVVD |
|---|---|---|
| Revenue CAGR (5Y) | -0.26% | N/A |
| Total return CAGR (5Y) | -20.07% | -51.69% |
Frequently asked
- How have AKBA and IVVD total returns compared?
- Over the past 5 years, AKBA delivered -20.07% and IVVD delivered -51.69% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Akebia Therapeutics ROEInvivyd ROEAkebia Therapeutics operating marginInvivyd operating marginAkebia Therapeutics revenue growthInvivyd revenue growthAkebia Therapeutics free cash flowInvivyd free cash flow
Akebia Therapeutics & Invivyd appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.